分支动脉粥样硬化疾病及治疗。

IF 2.3 4区 医学 Q3 CLINICAL NEUROLOGY
Brain Circulation Pub Date : 2022-12-06 eCollection Date: 2022-10-01 DOI:10.4103/bc.bc_56_22
Honglian Duan, Ho Jun Yun, Xiaokun Geng, Yuchuan Ding
{"title":"分支动脉粥样硬化疾病及治疗。","authors":"Honglian Duan,&nbsp;Ho Jun Yun,&nbsp;Xiaokun Geng,&nbsp;Yuchuan Ding","doi":"10.4103/bc.bc_56_22","DOIUrl":null,"url":null,"abstract":"<p><p>Branch atheromatous disease (BAD) is a subtype of ischemic stroke caused by perforating arteries occlusion due to proximal atherosclerosis of the arteries. Early neurological deterioration and recurrent stereotyped transient ischemic attacks are typical clinical manifestations of BAD. The optimal treatment for BAD has not been determined. This article explores a possible mechanism of BAD and effective treatment measures to prevent early progression and attack of transient ischemic events. This article explains the current status of intravenous thrombolysis, tirofiban, and argatroban for BAD and subsequent prognosis.</p>","PeriodicalId":9288,"journal":{"name":"Brain Circulation","volume":"8 4","pages":"169-171"},"PeriodicalIF":2.3000,"publicationDate":"2022-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e0/98/BC-8-169.PMC10167853.pdf","citationCount":"0","resultStr":"{\"title\":\"Branch atheromatous disease and treatment.\",\"authors\":\"Honglian Duan,&nbsp;Ho Jun Yun,&nbsp;Xiaokun Geng,&nbsp;Yuchuan Ding\",\"doi\":\"10.4103/bc.bc_56_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Branch atheromatous disease (BAD) is a subtype of ischemic stroke caused by perforating arteries occlusion due to proximal atherosclerosis of the arteries. Early neurological deterioration and recurrent stereotyped transient ischemic attacks are typical clinical manifestations of BAD. The optimal treatment for BAD has not been determined. This article explores a possible mechanism of BAD and effective treatment measures to prevent early progression and attack of transient ischemic events. This article explains the current status of intravenous thrombolysis, tirofiban, and argatroban for BAD and subsequent prognosis.</p>\",\"PeriodicalId\":9288,\"journal\":{\"name\":\"Brain Circulation\",\"volume\":\"8 4\",\"pages\":\"169-171\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2022-12-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e0/98/BC-8-169.PMC10167853.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain Circulation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4103/bc.bc_56_22\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/10/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain Circulation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/bc.bc_56_22","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

分支动脉粥样硬化性疾病(BAD)是由动脉近端动脉粥样硬化引起的穿通动脉闭塞引起的缺血性中风的一种亚型。BAD的典型临床表现是早期神经系统恶化和复发性定型的短暂性脑缺血发作。BAD的最佳治疗方法尚未确定。本文探讨了BAD的可能机制和有效的治疗措施,以防止短暂性脑缺血事件的早期进展和发作。本文介绍静脉溶栓、替罗非班和阿加曲班治疗BAD的现状以及随后的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Branch atheromatous disease and treatment.

Branch atheromatous disease (BAD) is a subtype of ischemic stroke caused by perforating arteries occlusion due to proximal atherosclerosis of the arteries. Early neurological deterioration and recurrent stereotyped transient ischemic attacks are typical clinical manifestations of BAD. The optimal treatment for BAD has not been determined. This article explores a possible mechanism of BAD and effective treatment measures to prevent early progression and attack of transient ischemic events. This article explains the current status of intravenous thrombolysis, tirofiban, and argatroban for BAD and subsequent prognosis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Brain Circulation
Brain Circulation Multiple-
自引率
5.30%
发文量
31
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信